According to Ikena Oncology's latest financial reports the company has a price-to-book ratio of 0.5219.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 0.5600 | -24.02% |
2022-12-31 | 0.7371 | -69.79% |
2021-12-31 | 2.44 | |
2020-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 1.38 | 164.95% | ๐บ๐ธ USA |